Ultrasound Measurement of Quadriceps Shortening During Neuromuscular Electrical Stimulation in Critically Ill Patients (DETECT)
Diagnostic Accuracy of Early ulTrasound Measurement of Quadriceps Thickness During Neuromuscular EleCTrical Stimulation for the Diagnosis of ICU-acquired Weakness : an Observational Study (DETECT)
Sponsor: Groupe Hospitalier du Havre
A observational or N/A phase clinical study on ICU Acquired Weakness and Quadriceps Muscle Atrophy, this trial is completed. The trial is conducted by Groupe Hospitalier du Havre and has accumulated 7 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Aug 2024 — Sep 2024 [monthly]
Completed
-
Jul 2024 — Aug 2024 [monthly]
Completed
-
Feb 2024 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2023 — Feb 2024 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Sep 2021 — Jan 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Sep 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Groupe Hospitalier du Havre
For direct contact, visit the study record on ClinicalTrials.gov .